Primary Generalized Tonic-Clonic Seizures research hub
3 indexed studies · 3 currently recruiting
- recruitingTherapeutic confirmatory (Phase III)
A Multicenter Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures
This study is looking at the long-term safety of a medicine called cenobamate for adults who have a certain type of seizure called primary generalized tonic-clonic seizures. It's an extension of a previous study, continuing to check how safe the medicine is over time.
Germany · Hungary · Spain - recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures
This study is testing a new medicine, cenobamate, for people in the UK and other countries who have a specific type of epilepsy seizure called Primary Generalized Tonic-Clonic seizures. Researchers want to see if it reduces how often these seizures happen and if it's safe to use.
Slovakia · Hungary · Spain - recruitingPHASE3
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
This study is testing a new medicine, XEN1101, alongside usual treatments for a specific type of epilepsy seizure called Primary Generalized Tonic-Clonic Seizures (PGTCS). It aims to see if the new medicine helps reduce these seizures and if it's safe for people aged 12 and older.
United States · Argentina · Australia